No, private label retinol body oils do not require premarket FDA approval to sell in the USA as long as they are formulated and marketed as cosmetics — meaning they make only cosmetic claims (moisturizes, smooths, improves skin appearance) and do not claim to treat or prevent a disease or alter the structure or function of the body in a drug-like way.
Retinol (vitamin A alcohol) at concentrations used in cosmetics (typically below 1%) is classified as a cosmetic ingredient in the US, not a drug. This distinguishes it from prescription-only tretinoin (retinoic acid), which is an FDA-regulated drug. As long as your retinol body oil is marketed with cosmetic-only claims, you are in the cosmetics regulatory lane.
However, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) significantly updated compliance obligations for cosmetics brands and manufacturers. As of December 2023–2024 (phased implementation), cosmetics manufacturers must register their facilities with the FDA and list their products and cosmetic ingredient statements in the FDA Cosmetics Direct system. This is not premarket approval — the FDA does not review or approve your formula before sale — but it is a legal requirement. Your US contract manufacturer should already be registered; confirm this before signing a manufacturing agreement.
From a labeling standpoint, your retinol body oil must comply with FDA 21 CFR Part 701 (cosmetic labeling regulations): the product's identity, net weight, distributor name and address, and a compliant INCI ingredient list in descending order of predominance. Retinol must appear on the label as "Retinol" per INCI nomenclature.
California's Proposition 65 is a state-level regulation worth flagging. Vitamin A (retinyl palmitate, a retinol ester) is listed as a potential carcinogen under Prop 65 in certain rinse-off applications. For a leave-on body oil, the exposure calculation and warning requirement depends on the specific retinol compound used and its concentration. Have your legal counsel or the manufacturer evaluate whether a Prop 65 warning is required for your formulation before you sell in California.
If you plan to sell in the EU or UK, the regulatory picture is different. The EU Cosmetics Regulation (EC 1223/2009) limits retinol in body lotions and body oils to 0.05%, and retinyl palmitate to 0.3% in body application products, under Annex III restrictions that came into effect in 2022. A Responsible Person must notify the product in the EU CPNP portal before sale. UK regulations mirror EU rules post-Brexit via the UK Cosmetics Regulation (GB law).
The practical takeaway: work with a US manufacturer who understands MoCRA compliance, can provide complete INCI documentation, and can support your Prop 65 exposure assessment if California is part of your distribution. AJ Cosmo Labs connects you with manufacturers who are already navigating this regulatory landscape daily.
Ingredients in this answer: Retinol · Retinyl Palmitate
Read the full guide on Private Label Retinol Body Oil Manufacturer USA Low MOQ →